ORIC Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Piscitelli Dominic unloaded Company’s shares for reported $0.2 million on Jul 01 ’25. In the deal valued at $10.05 per share,20,000 shares were sold. As a result of this transaction, Piscitelli Dominic now holds 48,317 shares worth roughly $0.5 million.
Then, Piscitelli Dominic sold 32,466 shares, generating $341,039 in total proceeds. Upon selling the shares at $10.50, the Chief Financial Officer now owns 68,317 shares.
Before that, Piscitelli Dominic sold 1,034 shares. ORIC Pharmaceuticals Inc shares valued at $10,344 were divested by the Chief Financial Officer at a price of $10.00 per share. As a result of the transaction, Piscitelli Dominic now holds 100,783 shares, worth roughly $1.05 million.
Ladenburg Thalmann initiated its ORIC Pharmaceuticals Inc [ORIC] rating to a Buy in a research note published on July 08, 2025; the price target was $15. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late October with a ‘”an Overweight”‘ rating. Stifel began covering ORIC with “Buy” recommendation on September 06, 2024. Cantor Fitzgerald started covering the stock on February 23, 2024. It rated ORIC as “an Overweight”.
Price Performance Review of ORIC
On Tuesday, ORIC Pharmaceuticals Inc [NASDAQ:ORIC] saw its stock fall -2.07% to $10.43. Over the last five days, the stock has gained 2.76%. ORIC Pharmaceuticals Inc shares have risen nearly 38.70% since the year began. Nevertheless, the stocks have risen 29.24% over the past one year. While a 52-week high of $14.67 was reached on 02/10/25, a 52-week low of $3.90 was recorded on 04/09/25.
Levels Of Support And Resistance For ORIC Stock
The 24-hour chart illustrates a support level at 10.19, which if violated will result in even more drops to 9.94. On the upside, there is a resistance level at 10.91. A further resistance level may holdings at 11.38.
How much short interest is there in ORIC Pharmaceuticals Inc?
A steep rise in short interest was recorded in ORIC Pharmaceuticals Inc stocks on 2025-06-13, growing by 1.03 million shares to a total of 12.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 11.69 million shares. There was a rise of 8.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 22, 2023 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $8 price target.
